Application
LASP1 Antibody (Center) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the LASP1 antibody detected the LASP1 protein (arrow).| Product Name | LASP1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LASP1; MLN50; LIM and SH3 domain protein 1; Metastatic lymph node gene 50 protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | MLN50 |
|---|---|
| Alternative Names | LASP1 MLN50 LIM and SH3 domain protein 1 Metastatic lymph node gene 50 protein |
| Molecular Weight(MW) | 29717 Da |
| Function | Plays an important role in the regulation of dynamic actin-based, cytoskeletal activities. Agonist-dependent changes in LASP1 phosphorylation may also serve to regulate actin-associated ion transport activities, not only in the parietal cell but also in certain other F-actin-rich secretory epithelial cell types (By similarity) |
| Tissue Specificity | This LASP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 119-148 amino acids from the Central region of human LASP1. |
| Cellular Localization | Cytoplasm, cell cortex (By similarity). Cytoplasm, cytoskeleton (By similarity). Note=Associated with the F-actin rich cortical cytoskeleton (By similarity) |
| Entrez Gene | 3927 |
|---|---|
| Nucleotide Accession | NP_006139.1 |
Application
LASP1 Antibody (Center) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the LASP1 antibody detected the LASP1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
